Brand pharmaceutical companies face the terminal crisis of.docVIP

 PAGE \* MERGEFORMAT 9 Brand pharmaceutical companies face the terminal crisis of First, brand-name pharmaceuticals dilemma facing the terminal Recently, the ‘China pharmacies’ magazine in Beijing, organized a ‘branded terminal crisis’ seminar attracted Xi’an Janssen, Johnson amp;amp; Johnson, United States SmithKline, Pfizer, three gold pharmaceuticals, Wanxi system medicine, CONBA pharmaceutical, Dongsheng science and technology, Simcere Pharmaceutical, Beijing Tong Ren Tang, step groups, Shenwei Pharmaceutical, amendment medicine, Liaoning Fushun, Ling Rui Pharma, Guangxi Tianhe Phar